Cornerstone Pharmaceuticals, Inc.
PrivateLast Round
Recap
Mar 13, 2024
Est. Valuation
$125M
Total Funding Raised
$39.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cornerstone Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that develops metabolic oncology therapeutics designed to treat cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cornerstone Pharmaceuticals, Inc. Comparables
Compare Cornerstone Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Advanced BioDesign | 78% | |
| ImmunoMet Therapeutics | 78% | |
| Faeth Therapeutics | 75% | |
Cornerstone Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Recap | Mar 13, 2024 | ||||
| VC Round | Jan 23, 2019 | ||||
| Series D | Sep 7, 2018 | ||||
| Series C | Sep 19, 2016 | ||||
| Convertible Debt | Sep 16, 2016 | ||||
Series B Extension | Jan 26, 2010 |
Cornerstone Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CS Pharma Holdings, LLC | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 75% MoM.
- May 3, 2025
Monthly visitors grew 72% MoM, reaching 1.6K.
Cornerstone Pharmaceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cornerstone Pharmaceuticals, Inc.'s valuation, stock price, and market status.